年龄对糖尿病下肢重建游离皮瓣术中脂质前列腺素E1输注后即刻动脉最大血流速度的影响
这项前瞻性观察研究在40例接受下肢重建游离皮瓣手术的糖尿病患者中,于输注0.4 μg/h脂质前列腺素E1(lipo-PGE1)前及输注30分钟后评估动脉蒂最大血流速度。整体未见显著差异,但多因素logistic回归显示年龄<65岁是lipo-PGE1输注后最大血流速度增加的唯一独立因素(OR=5.344,p=0.022)。
要点
- 糖尿病游离皮瓣患者输注lipo-PGE1后整体动脉最大血流速度无显著变化。
- 年龄<65岁是lipo-PGE1输注后血流速度增加的独立因素(OR=5.344,p=0.022)。
- 年龄可能影响lipo-PGE1对糖尿病游离皮瓣动脉血流的作用。
核心结论
- 不考虑年龄时,lipo-PGE1未显著增加糖尿病游离皮瓣动脉蒂最大血流速度。
- 考虑年龄时,lipo-PGE1可增加<65岁患者的血流速度,提示年龄影响其效应。
研究设计与样本
- 前瞻性观察研究,纳入40例接受下肢重建游离皮瓣手术的糖尿病患者。
- 在输注0.4 μg/h lipo-PGE1前及输注30分钟后评估动脉蒂最大血流速度。
- 采用多因素logistic回归分析年龄、HbA1c浓度、糖尿病病程和皮瓣类型与血流速度增加的关联。
主要发现
- lipo-PGE1输注前与输注30分钟后游离皮瓣最大血流速度无显著差异。
- 多因素logistic回归显示年龄<65岁是lipo-PGE1输注后最大血流速度增加的唯一独立因素(OR=5.344;p=0.022)。
关键数值与推荐
- lipo-PGE1输注剂量为0.4 μg/h。
- 年龄<65岁与lipo-PGE1输注后最大血流速度增加独立相关(OR=5.344;p=0.022)。
临床怎么用
- 对糖尿病下肢重建游离皮瓣患者,可考虑年龄因素评估lipo-PGE1改善动脉血流的潜在获益。
- 年龄<65岁患者可能更可能从lipo-PGE1输注中获得动脉最大血流速度增加。
局限性
- 本研究为前瞻性观察研究,样本量为40例糖尿病患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes mellitus may have a negative effect on free flap perfusion in patients undergoing reconstructive surgery. Little is known of the effects of lipo-prostaglandin E1 (lipo-PGE1) on flap blood flow in diabetes. This study investigated the effects of lipo-PGE1 on maximal blood flow velocity of the free flap arterial pedicle in patients with diabetes. METHODS: This prospective observational study assessed maximal blood flow velocity in the arterial pedicle before and 30 min after infusion of 0.4 μg/h lipo-PGE1 in 40 patients with diabetes who received a free flap for lower extremity reconstruction. Multivariate logistic regression analysis was performed to determine whether age, hemoglobin A1c concentration, duration of diabetes, and flap type were significantly associated with increased maximal blood flow velocity after lipo-PGE1 infusion or not. RESULTS: The maximal blood flow velocity of the free flap did not differ significantly before and 30 min after lipo-PGE1 infusion. Multivariate logistic regression analysis showed that age <65 years was the only independent factor associated with increased maximal blood flow velocity after lipo-PGE1 infusion (odds ratio = 5.344; p = 0.022). CONCLUSION: Assessments of all patients with diabetes undergoing free flap surgery, when age was not taken into consideration, found that lipo-PGE1 did not significantly increase the maximal blood flow velocity of the free flap arterial pedicle. However, when age was taken into consideration, lipo-PGE1 increased blood flow velocity in patients <65 years old, suggesting that age influences the effect of lipo-PGE1 on the blood flow velocity.
引用
- Park JY, Jin SJ, Suh HP, et al. The role of age in determining the effects of lipo-PGE1 infusion on immediate arterial maximal flow velocity in patients with diabetes undergoing free flap surgery for lower extremity reconstruction: A prospective observational study. J Plast Reconstr Aesthet Surg. 2019. PMID: 31924534. doi:10.1016/j.bjps.2019.11.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。